MIDATECH PHARMA
News | News Release
Jun 1, 2018
2017 Annual Report and AGM Notification

Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products in oncology and immunotherapy, is pleased to confirm that the 2017 Annual Report for the year ended 31 December 2017 has been sent to shareholders. The document is available today on the “Investors” section of the Company’s website at http://www.midatechpharma.com/investors/financial-reports.html.  
 
Midatech also announces that its AGM will be held on Wednesday 27 June 2018. The meeting will be held at Panmure Gordon & Co, 1 New Change, EC4M 9AF, London, commencing at 9:30 a.m.
 

News
News Release
Jun 1, 2018
2017 Annual Report and AGM Notification

Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products in oncology and immunotherapy, is pleased to confirm that the 2017 Annual Report for the year ended 31 December 2017 has been sent to shareholders. The document is available today on the “Investors” section of the Company’s website at http://www.midatechpharma.com/investors/financial-reports.html.  
 
Midatech also announces that its AGM will be held on Wednesday 27 June 2018. The meeting will be held at Panmure Gordon & Co, 1 New Change, EC4M 9AF, London, commencing at 9:30 a.m.
 

© Copyright 2018 Midatech Pharma PLC